These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 21801)

  • 21. Pressure-independent inhibition of sympathetic activity by noradrenaline: role of baroreceptor C fibres.
    Akre S; Aars H
    Acta Physiol Scand; 1977 Jul; 100(3):303-8. PubMed ID: 920201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The central and peripheral components in the action of cardioselective beta-adrenoblockaders].
    Medvedev OS; Tiurmina OA
    Farmakol Toksikol; 1991; 54(3):30-2. PubMed ID: 1680750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increase of renal sympathetic nerve activity by metoprolol or propranolol in conscious spontaneously hypertensive rats.
    Majcherczyk S; Mikulski A; Sjölander M; Thorén P
    Br J Pharmacol; 1987 Aug; 91(4):711-4. PubMed ID: 3664074
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms of action and the clinical pharmacology of beta-adrenergic blocking drugs.
    Lowenthal DT; Saris SD; Packer J; Haratz A; Conry K
    Am J Med; 1984 Oct; 77(4A):119-27. PubMed ID: 6148890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Propofol suppresses sympathetic activity and inhibits the baroreceptor reflex in waking rats].
    Tiurmina OA; Conlay LA; Medvedev OS
    Eksp Klin Farmakol; 1993; 56(2):21-4. PubMed ID: 8348029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiovascular pharmacology of ASL-7022. III. Peripheral vascular adrenergic mechanisms.
    Gorczynski RJ; Reynolds RD
    J Pharmacol Exp Ther; 1985 Mar; 232(3):629-35. PubMed ID: 2857783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of AT1 receptors in the central control of sympathetic vasomotor function.
    Head GA
    Clin Exp Pharmacol Physiol Suppl; 1996; 3():S93-8. PubMed ID: 8993846
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Haemodynamic effects of beta-adrenorecptor blockers in hypertension.
    Ablad B; Ljung B; Sannerstedt R
    Drugs; 1976; 11 SUPPL 1():127-34. PubMed ID: 6245
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adrenergic and non-adrenergic cardiovascular effects of thyrotropin-releasing hormone (TRH) in the anaesthetized rabbit.
    Seligsohn EE
    Acta Physiol Scand; 1992 Sep; 146(1):107-17. PubMed ID: 1359733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of arotinolol on hemodynamics and adrenergically induced renin release and renal vasoconstriction.
    Suzuki-Kusaba M; Hisa H; Kimura T; Satoh S
    Arzneimittelforschung; 1988 May; 38(5):671-7. PubMed ID: 2458109
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proceedings: effects of ketamine on central sympathetic discharge, circulatory and baroreceptor responses.
    McGrath JC; Mackenzie JE; Millar RA
    Br J Anaesth; 1975 May; 47(5):634. PubMed ID: 1138788
    [No Abstract]   [Full Text] [Related]  

  • 32. Beta-adrenoceptor blocking drugs in hypertension.
    Scriabine A
    Annu Rev Pharmacol Toxicol; 1979; 19():269-84. PubMed ID: 36828
    [No Abstract]   [Full Text] [Related]  

  • 33. [Phenothiazine derivatives, chlorpromazine and triflupromazine, produce different effects on sympathetic nerve activity in urethane-anesthetized rabbits].
    Ogura S
    Masui; 1994 Aug; 43(8):1179-90. PubMed ID: 7933499
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of baroreflex activation in the regional hemodynamic effects of the beta-blockers tertatolol and propranolol in conscious spontaneously hypertensive rats.
    Struyker-Boudier HA; van Essen H; Nievelstein HM; Smits JF
    Am J Nephrol; 1986; 6 Suppl 2():25-9. PubMed ID: 2879469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of brain natriuretic peptide on renal nerve activity in conscious rabbits.
    Morita H; Nishida Y; Motochigawa H; Kangawa K; Minamino N; Matsuo H; Hosomi H
    Am J Physiol; 1989 Mar; 256(3 Pt 2):R792-6. PubMed ID: 2923263
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacology of combined alpha-beta-blockade. II. Haemodynamic effects of labetalol.
    Lund-Johansen P
    Drugs; 1984; 28 Suppl 2():35-50. PubMed ID: 6151890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug.
    Brittain RT; Levy GP
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):681-4. PubMed ID: 10948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of d,l-propranolol on renal sympathetic baroreflex properties and aortic baroreceptor activity.
    Dorward PK; Korner PI
    Eur J Pharmacol; 1978 Nov; 52(1):61-71. PubMed ID: 214313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Blocking of beta-adrenoceptors in arterial hypertension].
    Aramendia P
    Medicina (B Aires); 1980; 40(4):467-77. PubMed ID: 6111016
    [No Abstract]   [Full Text] [Related]  

  • 40. Cardiovascular effects of YM-16151-1 and its optical isomers: a novel calcium entry blocking and beta 1-adrenoceptor blocking agent.
    Uchida W; Shibasaki K; Asano M; Takenaka T
    Arch Int Pharmacodyn Ther; 1993; 321():30-40. PubMed ID: 8100704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.